rs139145143
Positions:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP5BP4BS2
The NM_014049.5(ACAD9):c.1405C>T(p.Arg469Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000726 in 1,614,176 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00076 ( 2 hom. )
Consequence
ACAD9
NM_014049.5 missense
NM_014049.5 missense
Scores
10
9
Clinical Significance
Conservation
PhyloP100: 0.933
Genes affected
ACAD9 (HGNC:21497): (acyl-CoA dehydrogenase family member 9) This gene encodes a member of the acyl-CoA dehydrogenase family. Members of this family of proteins localize to the mitochondria and catalyze the rate-limiting step in the beta-oxidation of fatty acyl-CoA. The encoded protein is specifically active toward palmitoyl-CoA and long-chain unsaturated substrates. Mutations in this gene cause acyl-CoA dehydrogenase family member type 9 deficiency. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP5
Variant 3-128909019-C-T is Pathogenic according to our data. Variant chr3-128909019-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 214007.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=5}.
BP4
Computational evidence support a benign effect (MetaRNN=0.20564798). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACAD9 | NM_014049.5 | c.1405C>T | p.Arg469Trp | missense_variant | 14/18 | ENST00000308982.12 | NP_054768.2 | |
ACAD9 | NM_001410805.1 | c.1036C>T | p.Arg346Trp | missense_variant | 13/17 | NP_001397734.1 | ||
ACAD9 | XM_024453484.2 | c.1036C>T | p.Arg346Trp | missense_variant | 14/18 | XP_024309252.1 | ||
ACAD9 | NR_033426.2 | n.1653C>T | non_coding_transcript_exon_variant | 14/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACAD9 | ENST00000308982.12 | c.1405C>T | p.Arg469Trp | missense_variant | 14/18 | 1 | NM_014049.5 | ENSP00000312618 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152238Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
63
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000398 AC: 100AN: 251318Hom.: 0 AF XY: 0.000434 AC XY: 59AN XY: 135896
GnomAD3 exomes
AF:
AC:
100
AN:
251318
Hom.:
AF XY:
AC XY:
59
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000759 AC: 1109AN: 1461820Hom.: 2 Cov.: 35 AF XY: 0.000738 AC XY: 537AN XY: 727214
GnomAD4 exome
AF:
AC:
1109
AN:
1461820
Hom.:
Cov.:
35
AF XY:
AC XY:
537
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152356Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74492
GnomAD4 genome
AF:
AC:
63
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
23
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
26
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:3Benign:2
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 26, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | ACAD9: PM2, PS3:Supporting - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 11, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 469 of the ACAD9 protein (p.Arg469Trp). This variant is present in population databases (rs139145143, gnomAD 0.07%). This missense change has been observed in individuals with clinical features of mitochondrial complex I deficiency (PMID: 20929961, 30025539; Invitae). ClinVar contains an entry for this variant (Variation ID: 214007). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACAD9 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects ACAD9 function (PMID: 25721401). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Acyl-CoA dehydrogenase 9 deficiency Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 04, 2018 | The ACAD9 c.1405C>T (p.Arg469Trp) missense variant has been reported in one study in which it was identified in a compound heterozygous state with a second missense variant in one individual with mitochondrial complex I deficiency (Gerards et al. 2011). A muscle biopsy from the affected individual indicated a 91% reduction in mitochondrial complex 1 activity compared to control (Scholte et al. 1995). The p.Arg469Trp variant was absent from 233 controls and is reported at a frequency of 0.000744 in the European (non-Finnish) population of the Genome Aggregation Database. Recombinant Arg469Trp ACAD9 protein, derived from a bacterial expression system was stable and showed a mildly decreased enzyme activity compared to wild type (Schiff et al. 2015). Based on the evidence, the p.Arg469Trp variant is classified as a variant of unknown significance but suspicious for pathogenicity for ACAD9 deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 30, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 13, 2023 | Variant summary: ACAD9 c.1405C>T (p.Arg469Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0004 in 251318 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in ACAD9 causing Mitochondrial Complex I Deficiency, Nuclear Type 20 (0.0004 vs 0.0011), allowing no conclusion about variant significance. c.1405C>T has been reported in the literature in individuals affected with Mitochondrial Complex I Deficiency, Nuclear Type 20. These reports do not provide unequivocal conclusions about association of the variant with Mitochondrial Complex I Deficiency, Nuclear Type 20. At least one publication reports experimental evidence evaluating an impact on protein function and showed that variant effect results in about 80% of normal activity. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS n=5, likely pathogenic n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at